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ABSTRACT
Osteogenesis imperfecta (OI) is a genetic disorder leading to increased bone fragility. Recent work has shown that the
hierarchical structure of bone plays an important role in determining its mechanical properties and resistance to fracture.
The current study represents one of the first attempts to characterize the 3D structure and composition of cortical bone in
OI at the micron-scale. A total of 26 pediatric bone fragments from 18 individuals were collected during autopsy (Nc=5)
or routing orthopaedic procedures (NOI=13) and imaged by microtomography with a synchrotron light source (SRµCT)
for several microstructural parameters including cortical porosity (Ca.V/TV), canal surface to tissue volume (Ca.S/TV),
canal diameter (Ca.Dm), canal separation (Ca.Sp), canal connectivity density (Ca.ConnD), and volumetric tissue mineral
density (TMD). Results indicated significant differences in all imaging parameters between pediatric controls and OI
tissue, with OI bone showing drastically increased cortical porosity, canal diameter, and connectivity. Preliminary
mechanical testing revealed a possible link between cortical porosity and strength. Together these results suggest that the
pore network in OI contributes greatly to its reduced mechanical properties.
Keywords: Osteogenesis imperfecta, brittle bone disease, micro-computed tomography, synchrotron, cortical porosity,
bone microstructure, strength, pediatric bone

1. INTRODUCTION
Osteogenesis imperfecta (OI), or brittle bone disease, is the most common genetic bone disorder, affecting
approximately 1:10,000 persons.1 OI is generally characterized by mutations that lead to reduced quantity and/or quality
of type I collagen and its associated structural proteins. Collagen is an important organic constituent of many organ
systems throughout the body, and it is the most ubiquitous protein in animals.2 As a result, symptoms in OI vary widely
but can include a host of problems including brittle bones, spine deformities,3 impaired lung function,3 and heart valve
abnormalities,4 among others. Because of this heterogeneity, patients are generally classified into one of a growing
number of clinical groups (Table 1). However, in practice it is difficult to distinguish between types VI-VIII in children
on the basis of clinical or radiological features. Of the remaining groups, types I, IV, and III are the most commonly
studied, and these three types provide a good framework for comparing characteristics of mild, moderate, and severe OI,
respectively.
Until recently, the prevailing paradigm for assessing bone strength has been that changes in the loading environment
affect bone remodeling and mineralization, which in turn directly influence mechanical properties.5 However, bone is a
composite of flexible collagen and brittle hydroxyapatite mineral, and as such its properties depend not only on the
composition but also on the structure or organization of the tissue. Cortical bone has a highly complex, hierarchical
structure (Figure 1) that is often difficult or impractical to assess in patients because the resolution of in vivo imaging

techniques is limited. The radiation dose of X-ray based methods is also of particular concern in pediatric OI patients,
who routinely undergo X-rays for fractures and surgical planning.
Table 1. Clinical classification of OI patients (Adapted from Van Dijk, et al6). *Denotes types included in the current study.

Clinical type

Severity

Affected gene (and associated protein)

I*

Mild (non-deforming)

COL1A1/2 (type I collagen)

II

Lethal (perinatal)

COL1A1/2 (type I collagen)

III*

Severe

COL1A1/2 (type I collagen)

IV*

Moderate

COL1A1/2 (type I collagen)

V

Moderate

Unknown

VI

Moderate/severe

Unknown

VII

Moderate

CRTAP (cartilage associated protein)

VIII

Severe/lethal

LEPRE1 (leucine proline-enriched proteoglycan)

Figure 1. Hierarchical structure of cortical bone (with associated length scales).

The emergence of ex vivo imaging techniques such as micro-computed tomography (µCT) for biomedical applications
has made it possible to explore small structures (e.g., osteons, osteocyte lacunae, vasculature, etc.) in the interior of bone
at a vastly improved level of resolution. Continuous advances in computational power have enabled complex analysis of
bone porosity using direct 3D measurements that do not rely on stereological or material distribution assumptions.
Although the availability of synchrotron user facilities is low (and the demand for beamtime high), these systems
provide an ideal tool for visualizing the micron-scale characteristics of bone.7 The vast majority of fractures in OI occur
in the long bones of the arms and legs (i.e., femur, tibia, humerus, radius). The purpose of this study was therefore to
characterize porosity and composition in small, clinically relevant fragments from the mid-diaphysis of long bones. A
secondary aim was to explore possible relationships between OI bone structure, mineralization, and strength.

2. METHODS
2.1 Study population
Pediatric patients with OI often require corrective surgeries and osteotomies that yield small bone fragments, which
would normally be discarded post-operatively or saved for histological analysis. After obtaining written consent/assent
and IRB approval (Rush University Medical Center #10101309 and Marquette University #HR-2176), we collected 21
such fragments from the femur, tibia, and humerus of 13 children with OI. We also collected 5 specimens from pediatric
controls due to autopsy (LBL BUA#205). Table 2 summarizes relevant donor information. All specimens were stored
fresh-frozen until just prior to testing.
Table 2. Study population. *Note: N=total number of donors, n=total number of specimens.

Control (Nc=5, n=5)

OI (NOI=13, n=21)

Phenotype

All healthy
(no known musculoskeletal disease)

Age, years [interquartile range]
Gender

7 [3-11]
All female

Anatomical location

All femur

Mild (type I): n=4
Moderate (type IV): n=5
Severe (type III): n=12
10 [8-12]
Male: n=10
Female: n=11
Femur: n=8
Tibia: n=11
Humerus: n=2

2.2 Synchrotron radiation µCT (SRµCT) imaging
All bone fragments were imaged (continuous mode, 1025 projections, 180° rotation) on the tomography beamline at the
Advanced Light Source (BL 8.3.2, Berkeley, CA) using a monochromatic X-ray energy of 17 keV. To reduce phase
contrast effects and improve resolution, we used the beamline’s newly commissioned Optique Peter X-ray microscope
(Lentilly, France), which allows for closer (i.e., <5mm) scintillator-to-objective distances. This system, along with the
other relevant beamline hardware and software, has been described previously. 8 A combination of the 4x and 10x
objective lenses was used, with resulting nominal pixel sizes of 1.7 µm and 0.6 µm, respectively. After flat field
correction, subsequent reconstructions were performed using a filtered back projection algorithm in Octopus commercial
software (Octopus 8.6, inCT, Ghent, Belgium) to generate scaled, 16-bit TIF stacks. The linear scaling equation was
embedded in the header file so that floating point gray values could be recovered for composition measurements.
2.3 K2HPO4 tissue phantom
Hydroxyapatite (HA) solutions have commonly been used as tissue phantoms to create calibration curves relating the
reconstructed gray values (which represent the linear attenuation coefficient, µ, of a material) to known mineral
concentrations.12 However, the resolution of SRµCT is fine enough to detect small inhomogeneities in these solutions,
and recent work has shown that dipotassium hydrogen phosphate (K2HPO4) solutions provide better results.13 A stock
solution of K2HPO4 was therefore prepared in nanopure water and diluted to create the following concentrations (g
K2HPO4/cm3): 0, 200, 400, 800, 1000. A small amount of each solution was placed in thin-walled glass capillary tubes
(SiO2, t=0.5 mm) and imaged in a similar manner to above. The resulting calibration curve is shown in Figure 2.

Figure 2. Bone phantom calibration curve. Each data point corresponds to the image above.

2.4 Microstructural and composition measurements
All reconstructed data sets were analyzed and visualized using the open-source software suite Fiji, a distribution of
ImageJ.14 Regions of interest (ROIs) were selected along a 1-mm section of each image stack. After filtering each ROI
using a 3D bilateral filtering algorithm,9 segmentation was performed using the built-in iterative IsoData thresholding
algorithm10 on the stack histogram. The pore structure was separated into canals and osteocyte lacunae using the Particle
Analyser algorithm in Fiji.
Microstructural parameters were then measured using BoneJ,11 a set of customizable plugins for Fiji. Table 3 shows a list
of all parameters calculated, along with physical descriptions for each parameter. 3D methods for calculating canal
diameter (Ca.Dm) and canal separation (Ca.Sp) were based on maximum inscribed sphere algorithms; consequently,
processing time was highly dependent on the size of the image features. To maximize computational efficiency, we
downsampled each ROI prior to performing these measurements.
Compositional measurements require accurate, quantitative analysis of image gray values. Therefore we converted the
images back to their floating point values and segmented in a similar manner to above. Each ROI was then analyzed to
determine the average gray value of all voxels that had been segmented as bone. Using the calibration curve generated
from the different concentrations of the K2HPO4 bone phantom (Figure 2), this average gray value was converted to a
volumetric tissue mineral density (TMD, in g/cm3).

Table 3. Summary of cortical bone microstructural parameters.

Microstructural parameter

Units

Description

Cortical porosity, Ca.V/TV

%

Volume of all haversian and Volkmann’s canals, including any
additional void space (excluding osteocyte lacunae and
canaliculi), divided by the total ROI volume

Canal surface to tissue volume, Ca.S/TV

mm-1

Total surface area of the pore network (calculated using a
marching cubes algorithm) divided by the total ROI volume

Canal diameter, Ca.Dm

µm

Average diameter of all voids (calculated using a maximum
inscribed sphere algorithm)

Canal separation, Ca.Sp

µm

Average distance between voids (calculated using a maximum
inscribed sphere algorithm)

Canal connectivity density, Ca.ConnD

mm-3

Number of connected structures in the pore network (calculated
using the Euler characteristic) divided by the total ROI volume

2.5 Pilot mechanical testing
To determine whether porosity is an important factor affecting bone strength, we tested a subset of the specimens to
failure in either three-point bending or tension. A total of 10 beams were machined, 5 each from control and severe (type
III) OI, using a low-speed diamond saw under constant water irrigation. Beams were machined such that the direction of
osteons was aligned parallel to the long axis of the beam. OI beams were tested to failure using a customized 3-point
bending jig attached to a materials testing frame (Instron, Model 3345, Norwood, MA),15 while control beams were
tested using a custom-made tensile rig (Omega, LC703-10).16 The two groups were tested under different loading
conditions because they were to be included in other related work. To ensure physiologically relevant strength results, all
beams remained hydrated throughout testing. The resulting load versus displacement curves were normalized to create
stress versus strain curves, where the strength was defined as the maximum stress achieved before failure.
2.6 Statistics
For the microstructural and compositional imaging data, the OI specimens were pooled and compared to the control
population using a Mann Whitney U test with a significance level of 0.05. Linear correlations were also calculated to
investigate possible relationships between the microstructural, compositional, and strength results.

3. RESULTS
3.1 Microstructural & compositional results
OI bone displayed statistically significant (p<0.05) differences across all microstructural measurements (Table 4). There
was an increase in cortical porosity (7x), canal surface to tissue volume (2x), canal diameter (3x), and canal connectivity
density (8x) for the OI bone compared to controls. The range of values for each parameter was much higher in OI bone
compared to controls, indicating a high degree of heterogeneity in the pore network. There were no obvious trends
between the different types of OI bone. The volume renderings in Video 1 show representative pore networks for each
experimental group. Although there does appear to be a consistent orientation of pores parallel to the direction of
osteons, the OI network shows higher variability and generally appears more isotropic than controls. There was no
apparent correlation between cortical porosity and tissue mineral density in the OI group. There was, however, a strong
negative correlation (R2=0.92) between these two parameters in pediatric controls.

Table 4. Microstructural & compositional results summary. All values listed as median [interquartile range]. *Denotes p<0.05
between pediatric controls and OI (pooled).

Parameter

Pediatric
controls

OI
(pooled)

Mild OI
(type I)

Moderate OI
(type IV)

Severe OI
(type III)

Cortical porosity, Ca.V/TV (%)

3.3
[3.0-3.4]
3.0
[2.8-3.1]
41
[29-42]
195
[177-197]
8.5
[2.5-14.9]
3.6
[3.6-3.7]

21.1*
[14.4-23.4]
6.2*
[5.4-8.2]
126*
[102-137]
253*
[215-333]
67.7*
[39.7-126.5]
2.5*
[2.4-2.7]

22.9
[19.0-26.3]
7.7
[6.2-9.3]
107
[101-116]
175
[148-338]
151.9
[87.3-252.3]
2.8
[2.7-2.9]

14.4
[13.5-23.4]
5.5
[4.0-7.3]
130
[101-133]
335
[301-435]
61.2
[20.0-101.6]
2.3
[2.3-2.4]

19.7
[15.8-22.7]
6.1
[5.6-8.3]
131
[119-149]
249
[219-311]
67.7
[50.5-97.9]
2.5
[2.4-2.6]

Canal surface to tissue volume,
Ca.S/TV (mm-1)
Canal diameter, Ca.Dm (µm)
Canal separation, Ca.Sp (µm)
Canal connectivity density,
Ca.ConnD (mm-3)
Tissue mineral density, TMD
(g/cm3)

A.

C.

B.

D.

Video 1. Comparison of cortical bone pore network (red=pores, yellow=osteocyte lacunae). A: Pediatric controls; B: Mild (type
I) OI; C: Moderate (type IV) OI; D: Severe (type III) OI. *Note: Osteocyte lacunae shown for reference but not included in
porosity calculations. For colorized video, see online version of paper: http://dx.doi.org/doi.number.goes.here

3.2 Preliminary mechanical results

Strength (σbend, MPa)

Initial results from bending tests indicated a correlation between cortical porosity and flexural strength in severe OI bone
(Figure 3). There was no apparent correlation between these parameters in the control group. Median strength values for
the control and OI groups tested in tension and bending, respectively, were 94 MPa and 76 MPa. However, since these
groups were tested under different experimental conditions, they should not be compared directly.

120
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R² = 0.5419

40
0
0
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Figure 3. Correlation between cortical porosity and strength in severe OI.

4. DISCUSSION/CONCLUSIONS
Although bone structure is an important determinant of mechanical properties, to date there is very little data examining
this topic in the OI literature. Several histological studies have reported on the cortical wall thickness at the iliac crest.1719
The most extensive of these analyzed 70 pediatric biopsies from mild, moderate, and severe OI patients, finding
marked cortical thinning across all types.19 It is unclear how well these measurements translate to other skeletal sites
such as the long bones, which are the most common fracture locations (and thus the most clinically relevant regions in
assessing fracture risk) in OI patients. One recent study used high-resolution peripheral quantitative computed
tomography (HR-pQCT) to analyze bone composition and structure in vivo at the ultradistal radius and ultradistal tibia in
adult patients with mild (type I) OI.20 The study reported decreases in OI volumetric bone mineral density and several
trabecular parameters; however, the resolution was too low (≈80 µm) to analyze the entire canal network. Alternatively,
SRµCT is well-suited for capturing the 3D, micron-scale properties of the bone tissue and canal network.7 This is
significant because recent work on the effects of aging has shown that microstructural features such as haversian canals
play an important role in resisting fracture. 21 The purpose of the current study was to characterize the cortical bone pore
network in mild (type I), moderate (type IV), and severe (III) OI, as well as to compare these groups to a pediatric
control population.
We observed drastic increases in porosity, canal diameter, and canal connectivity across all OI types. Whereas bone
tissue from the control group displayed a highly oriented canal network, OI bone was much more heterogeneous, with
large fluctuations in canal diameter and organization. These characteristics should impair bone strength, as large,
connected pores offer little resistance to crack propagation. Indeed, preliminary mechanical property data reflected this
relationship with structure, as there appeared to be a negative correlation between cortical porosity and strength in severe
OI bone. These results warrant an expanded study to investigate the relative importance of porosity in determining
strength.
The effect of OI severity was not readily noticeable in our analysis, as both microstructural and compositional measures
were similar between the three groups. Although not statistically significant, the fact that mild (type I) OI bone showed
the highest cortical porosity of the three groups is surprising. A total of 11 of the 13 OI donors (including all of the type I
donors) in this study had been treated with bisphosphonates, which alter mineral metabolism by reducing the activity of
bone-resorbing osteoclasts. Differences in the dosage and frequency of drug administration could help explain some of

the pore network variability between the OI groups. A recent nanoindentation study revealed that tissue level elastic
modulus (a measure of material stiffness) was approximately 7% higher in mild (type I) versus moderate and severe
OI.22 These findings suggest that there may be material level adaptations in mild OI bone that allow it to be stronger than
the other types despite higher porosity. To investigate this possibility, future work is needed combining detailed drug
history information with pore network analysis, as well as local mineralization and materials testing.
Overall compositional results were mixed, as we found a strong inverse correlation between cortical porosity and
volumetric tissue mineral density in the control group, but not in OI. This observation is interesting because previous
studies have shown a correlation between mineral measurements and bone volume fraction (BV/TV, a corollary to
cortical porosity) in trabecular OI bone.23 Bone turnover is elevated in OI19, and in general turnover is higher in
trabecular versus cortical bone.24 Together these findings point to fundamental differences in bone modeling/remodeling
between these two types of bone.
Because it is often difficult to obtain and test human OI bone specimens, mouse models have become a useful surrogate
for understanding the disease and evaluating potential treatment therapies. A recent pilot study on the oim model of
severe OI found an increase in the number of canals and osteocyte lacunae in diseased mice versus controls. 25 The
researchers suggested that the increase in the number of pores in oim bone may help explain the reduced fracture
resistance of this tissue. In contrast with our results, the study did not observe increased canal size or cortical porosity in
diseased bone. There are fundamental differences between the microstructure of murine versus human bone that could
explain this phenomenon (e.g., murine cortical bone does not contain osteons). In light of our current findings, a more
detailed study on oim bone is warranted to determine whether there are common characteristics in the pore network
between these species.
In summary, this study presents some of the first data on the 3D characteristics of the cortical bone pore network in mild,
moderate, and severe OI. We report significant increases in cortical porosity, canal diameter, and canal connectivity in
OI bone compared to a pediatric control group. Preliminary mechanical studies indicate a possible correlation between
cortical porosity and mechanical strength in OI bone. Future studies focusing on pore architectural characteristics such as
canal orientation, canal branching, and degree of anisotropy will shed further light on the effect of bone microstructure
on mechanical properties. Together this information will be valuable in understanding the cause of bone fragility in OI,
as well as in developing and evaluating new treatment strategies.
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